• Nenhum resultado encontrado

[PDF] Top 20 HBV-related hepatocellular carcinoma susceptibility gene KIF1B is not associated with development of chronic hepatitis B.

Has 10000 "HBV-related hepatocellular carcinoma susceptibility gene KIF1B is not associated with development of chronic hepatitis B." found on our website. Below are the top 20 most common "HBV-related hepatocellular carcinoma susceptibility gene KIF1B is not associated with development of chronic hepatitis B.".

HBV-related hepatocellular carcinoma susceptibility gene KIF1B is not associated with development of chronic hepatitis B.

HBV-related hepatocellular carcinoma susceptibility gene KIF1B is not associated with development of chronic hepatitis B.

... step of HCV-induced HCC develop- ment . The genome-wide analyses on loss of heterozygosity (LOH) in HCC by Li et ...LOH of 1p36.21–36.32 region was significant related to HCC ... See full document

4

Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in Qidong, China.

Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in Qidong, China.

... HCC development, and this may be related with the oncogenic properties of this mutant virus ...potential of pre-S2 deletions, compared with that of pre-S1 ...risk ... See full document

8

Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection.

Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection.

... Investigation of cancer-specific miRNAs in the circulation is an emerging and exciting field of ...One of the first studies measuring miRNA levels in serum was reported by Lawrie et ...levels ... See full document

8

GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers.

GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers.

... imputation of the region did not reveal any SNPs that showed stronger association than ...which is involved in the glutamate signaling, as one of the ionotropic glutamate receptor, kainite 1 ... See full document

8

Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort.

Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort.

... to chronic inflammation, the integration of HBV DNA into the host hepatocyte DNA and the expression of viral proteins, which transactivate human oncogenes, may play a role in ... See full document

9

Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus-related hepatocellular carcinoma.

Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus-related hepatocellular carcinoma.

... It is well known that AFP-L3 concentration correlates well with AFP; however, AFP-L3% is not correlated with AFP ...AFP-L3% is a marker that is independent of ... See full document

7

A Non-Synonymous Single Nucleotide Polymorphism in the HJURP Gene Associated with Susceptibility to Hepatocellular Carcinoma among Chinese.

A Non-Synonymous Single Nucleotide Polymorphism in the HJURP Gene Associated with Susceptibility to Hepatocellular Carcinoma among Chinese.

... combined with at least one positive image on angiography, sonography, and/or high-resolution contrast computed ...also chronic HBV carriers, and the selection criteria for them included no individual ... See full document

15

The emergence of YMDD mutants precedes biochemical flare by 19 weeks in lamivudine-treated chronic hepatitis B patients: an opportunity for therapy reevaluation

The emergence of YMDD mutants precedes biochemical flare by 19 weeks in lamivudine-treated chronic hepatitis B patients: an opportunity for therapy reevaluation

... loss of therapeutic efficacy associated with the development of resistance to lamivudine (LMV) and the availability of new alterna- tive treatments for chronic ... See full document

10

Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.

Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.

... All of the liver-related seromarkers we analyzed are associated with liver diseases such as fibrosis, cirrhosis, jaundice, and fatty ...status of the liver, such as liver cells injury, ... See full document

11

Pre-S deletion and complex mutations of hepatitis B virus related to young age hepatocellular carcinoma in Qidong, China.

Pre-S deletion and complex mutations of hepatitis B virus related to young age hepatocellular carcinoma in Qidong, China.

... strengths of this study include the sequence analysis of a series of serum samples from a community-based cohort study, repeated sequence analysis provides data on the long-term stability of ... See full document

7

A 3' UTR SNP in COL18A1 is associated with susceptibility to HBV related hepatocellular carcinoma in Chinese: three independent case-control studies.

A 3' UTR SNP in COL18A1 is associated with susceptibility to HBV related hepatocellular carcinoma in Chinese: three independent case-control studies.

... Hepatocellular carcinoma (HCC) is one of the most common malignancy and ranks fifth in men and eighth in women among causes of cancer mortality ...It is estimated that about ... See full document

6

Rev. Bras. Reumatol.  vol.52 número4 en v52n4a15

Rev. Bras. Reumatol. vol.52 número4 en v52n4a15

... patients with rheumatoid arthritis unresponsive to conven- tional disease-modifying antirheumatic ...Increased susceptibility to infections induced by these drugs is the main complication of ... See full document

3

Occult HBV Infection Reactivation in Non-Hodgkin’s Lymphoma: An Update on Prevalence and Management

Occult HBV Infection Reactivation in Non-Hodgkin’s Lymphoma: An Update on Prevalence and Management

... patients is not ...diagnose HBV reactivation varied widely across the diferent studies and thus also the deinition of OBI ...majority of the studies, especially those in a small ... See full document

9

Virus analysis of hepatocellular carcinoma "non-A, non-C" and hepatitis B virus.

Virus analysis of hepatocellular carcinoma "non-A, non-C" and hepatitis B virus.

... do HBV nos pacientes portadores de CHC qualificados de “não-B, não- C”, é ...genoma HBV de certos pacientes poderá explicar a ausência de marcadores deste vírus, notadamente o AgHBs ... See full document

1

Arq Bras Endocrinol Metab  vol.55 número9

Arq Bras Endocrinol Metab vol.55 número9

... and chronic hepatitis C in non-dia- betic patients was very interesting ...resistance is often present in patients with chronic hepatitis C, and this parameter is ... See full document

1

Rev. Soc. Bras. Med. Trop.  vol.47 número2

Rev. Soc. Bras. Med. Trop. vol.47 número2

... did not include a longitudinal follow-up. The ultrasounds may not have been uniform in terms of operator and evaluation method, as this was not a prospective ...presents with LS. As we ... See full document

7

Association of T174M polymorphism of angiotensinogen gene with essential hypertension: A meta-analysis

Association of T174M polymorphism of angiotensinogen gene with essential hypertension: A meta-analysis

... fect of the T174M variant on plasma AGT levels may vary among different ethnic groups so that the association be- tween T174M polymorphism and risk of essential hyper- tension may not be detected in ... See full document

7

Rev. Soc. Bras. Med. Trop.  vol.46 número4

Rev. Soc. Bras. Med. Trop. vol.46 número4

... limitations of this study included the cross-sectional format, which prevented the assessment of risk factors since exposure and outcome are measured at the same ...does not guarantee the reliability ... See full document

5

Clinical trial of lamivudine in children with chronic hepatitis B.

Clinical trial of lamivudine in children with chronic hepatitis B.

... tiation of therapy, every eight weeks until week 48, and at week ...patients with childbear- ing potential were required to have a pregnancy test at every study ...aware of the results of ... See full document

8

Arq Bras Endocrinol Metab  vol.55 número6

Arq Bras Endocrinol Metab vol.55 número6

... out with Abbott ...ratio of prothrombin time (INR) was determined with ISI and PT-Fib recombinant reagent and proces- sed in an ACL 3000 device, with ISI determined by the ...determined ... See full document

7

Show all 10000 documents...